Reipet – Lifestyle
Author:
Cantargia
Cantargia Announces AACR 2026 Presentation of Study Design and Supportive Pre-Clinical Data for Investigator-Initiated Nadunolimab Study in MSS CRC
April 17, 2026
Notice of Annual General Meeting in Cantargia AB (publ)
April 17, 2026
Cantargia Publishes Annual Report 2025
April 17, 2026
New Preclinical Data on Anti-Tumor Effects of Nadunolimab in Metastatic Colorectal Cancer Presented at the Keystone Cancer Immunotherapy Conference
March 18, 2026